
07/22/2025
Cancer screening is changing. We are proud to be part of that progress. And now, you can join us. 💛
We are proud to be part of the Vanguard Study, a national research effort to evaluate new multi-cancer detection (MCD) blood tests. These innovative tests can screen for multiple types of cancer—including bladder, breast, lung, and pancreatic—through a simple blood draw.
We're recruiting participants to join this cancer screening clinical trial. Adults ages 45-75 who have not had a cancer diagnosis in the past five years are eligible to enroll.
The results will help shape the future of early cancer detection and potentially change how cancer is first detected and treated.
📍Link in bio to learn more.